Electronic Brachytherapy for Nonmelanoma Skin Cancer
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Governs coverage and coding for electronic brachytherapy as a treatment for nonmelanoma skin cancer for Blue Cross Blue Shield - Rhode Island members across Medicare Advantage and Commercial products.
No material clinical or coverage changes in this revision.
Coverage Determination and Rationale
Coverage determination
Covered when ALL of the following are met:
Decision based on insufficient evidence, including absence of randomized controlled trials comparing electronic brachytherapy with alternative treatments
Electronic brachytherapy for the treatment of nonmelanoma skin cancer is not covered for Medicare Advantage plans and is considered not medically necessary for Commercial products. This determination reflects the policy's conclusion that the available evidence is insufficient to determine the effects of electronic brachytherapy on health outcomes.
This medical policy is provided for informational purposes and is subordinate to the member's subscriber agreement, member certificate, or employer agreement; those contractual documents take precedence over the policy. For member-specific benefits and eligibility, providers should contact the provider call center. The policy is not a guarantee of payment.
For Commercial products, electronic brachytherapy is considered not medically necessary because the evidence is insufficient to determine its effects on health outcomes. The evidence base includes systematic reviews, prospective cohorts, and case series but lacks randomized controlled trials directly comparing electronic brachytherapy with surgical or other radiotherapy alternatives; therefore, efficacy and safety relative to established treatments remain unproven.
Relevant Diagnosis and Procedure Codes
| 77436 | Surface radiation therapy; superficial or orthovoltage, treatment planning and simulation-aided field setting (New Code Effective 1/1/2026) |
| 77437 | Surface radiation therapy; superficial, delivery, </=150 kv, per fraction (eg, electronic brachytherapy) (New Code Effective 1/1/2026) |
| 77438 | Surface radiation therapy; orthovoltage, delivery, >150-500 kv, per fraction (New Code Effective 1/1/2026) |
| 77439 | Surface radiation therapy; superficial or orthovoltage, image guidance, ultrasound for placement of radiation therapy fields for treatment of cutaneous tumors, per course of treatment (list separately in addition to code for primary procedure) (New Code Effective 1/1/2026) |
| 0394T | High dose rate electronic brachytherapy, skin surface application, per fraction, includes basic dosimetry, when performed (Code Deleted Effective 12/31/2025) |
| C44.00 - C44.99 | Malignant neoplasm of skin (ICD-10 diagnosis code range) |
Provider Responsibilities, Billing, and Denial Risk
Prior authorization not required
Prior authorization is not applicable for electronic brachytherapy per this policy.
Verify member benefits and eligibility
Verify member-specific benefits and eligibility before scheduling treatment by contacting the provider call center; benefits and eligibility are determined by the member's subscriber agreement or employer agreement and supersede this policy.
- Call the provider call center for member-specific coverage details.
Provider billing reminder for electronic brachytherapy
Claims for electronic brachytherapy codes filed with ICD-10 diagnoses in the C44.00–C44.99 range are identified in the policy as subject to coverage restriction and denial (see billing/coding list).
Billing and documentation guidance for coded claims
When billing, the policy lists specific CPT/HCPCS procedure codes that are considered not covered for Medicare Advantage and not medically necessary for Commercial products when filed with ICD-10 diagnosis codes C44.00–C44.99; include appropriate documentation but note these code/diagnosis combinations are listed as non-covered/not medically necessary.
Confirm member benefits and agreement terms
Benefits and eligibility are determined by the member's subscriber agreement or employer agreement; providers must verify member-specific benefits via the provider call center before providing services.
- Subscriber agreements and employer agreements supersede this medical policy.
- Contact the provider call center for member-specific benefit information.
Denial triggers for electronic brachytherapy claims
Claims for electronic brachytherapy procedure codes filed with ICD-10 diagnosis codes C44.00–C44.99 are considered not covered for Medicare Advantage plans and not medically necessary for Commercial products and therefore are subject to denial.
Member financial responsibility risk
If services are determined to be not medically necessary (or are medically necessary but non-covered benefits), the provider may be prohibited from charging the member unless the member has been informed and has provided prior written agreement to accept financial responsibility.
- Obtain prior written agreement from the member before billing the member for non-covered or not medically necessary services.
Clinical Background
Nonmelanoma skin cancers (NMSC) primarily include basal cell carcinoma and squamous cell carcinoma of the skin. These tumors are common and are most often managed with surgical approaches; radiotherapy is an alternative when surgery is not feasible. Electronic brachytherapy is a localized radiotherapy technique that uses a miniaturized electronic X‑ray source and fitted surface applicators to deliver focused doses to superficial, well-circumscribed skin lesions over multiple treatment sessions. Available evidence consists mainly of case series, cohort studies, and systematic reviews; no randomized controlled trials comparing electronic brachytherapy with other treatments were identified, leaving uncertainty about comparative efficacy, long-term control, and safety.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.